Citigroup’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $471K | Sell |
36,757
-194,399
| -84% | -$2.48M | ﹤0.01% | 3587 |
|
|
2025
Q4 | $2.08M | Buy |
231,156
+141,488
| +158% | +$1.95M | ﹤0.01% | 2629 |
|
|
2025
Q3 | $1.55M | Sell |
89,668
-55,113
| -38% | -$679K | ﹤0.01% | 2883 |
|
|
2025
Q2 | $1.36M | Sell |
144,781
-152,625
| -51% | -$1.25M | ﹤0.01% | 2977 |
|
|
2025
Q1 | $2.11M | Buy |
297,406
+20,476
| +7% | +$207K | ﹤0.01% | 2654 |
|
|
2024
Q4 | $3.23M | Buy |
276,930
+109,370
| +65% | +$1.71M | ﹤0.01% | 2409 |
|
|
2024
Q3 | $3.44M | Buy |
167,560
+59,178
| +55% | +$1.36M | ﹤0.01% | 2173 |
|
|
2024
Q2 | $2.43M | Sell |
108,382
-234,584
| -68% | -$5.59M | ﹤0.01% | 2187 |
|
|
2024
Q1 | $9.43M | Buy |
342,966
+175,360
| +105% | +$4.87M | 0.01% | 1288 |
|
|
2023
Q4 | $5.11M | Sell |
167,606
-97,798
| -37% | -$2.81M | 0.01% | 1578 |
|
|
2023
Q3 | $8.39M | Buy |
265,404
+94,363
| +55% | +$3.66M | 0.01% | 1181 |
|
|
2023
Q2 | $6.98M | Buy |
171,041
+14,953
| +10% | +$606K | 0.01% | 1305 |
|
|
2023
Q1 | $5.82M | Buy |
156,088
+56,967
| +57% | +$2.23M | 0.01% | 1424 |
|
|
2022
Q4 | $3.46M | Sell |
99,121
-17,681
| -15% | -$841K | ﹤0.01% | 1686 |
|
|
2022
Q3 | $6.54M | Buy |
116,802
+15,307
| +15% | +$950K | 0.01% | 1387 |
|
|
2022
Q2 | $5.25M | Sell |
101,495
-237,291
| -70% | -$12M | 0.01% | 1511 |
|
|
2022
Q1 | $24.6M | Buy |
338,786
+273,107
| +416% | +$23.1M | 0.03% | 835 |
|
|
2021
Q4 | $7.77M | Sell |
65,679
-6,373
| -9% | -$798K | 0.01% | 1546 |
|
|
2021
Q3 | $9.66M | Buy |
72,052
+5,239
| +8% | +$793K | 0.01% | 1436 |
|
|
2021
Q2 | $10.8M | Sell |
66,813
-7,477
| -10% | -$582K | 0.01% | 1364 |
|
|
2021
Q1 | $5.96M | Buy |
74,290
+58,358
| +366% | +$3.92M | 0.01% | 1674 |
|
|
2020
Q4 | $868K | Sell |
15,932
-9,529
| -37% | -$346K | ﹤0.01% | 3678 |
|
|
2020
Q3 | $506K | Sell |
25,461
-15,295
| -38% | -$319K | ﹤0.01% | 3833 |
|
|
2020
Q2 | $857K | Sell |
40,756
-3,203
| -7% | -$54.4K | ﹤0.01% | 3721 |
|
|
2020
Q1 | $538K | Sell |
43,959
-20,767
| -32% | -$280K | ﹤0.01% | 3810 |
|
|
2019
Q4 | $950K | Sell |
64,726
-38,396
| -37% | -$534K | ﹤0.01% | 3807 |
|
|
2019
Q3 | $1.38M | Buy |
103,122
+54,587
| +112% | +$870K | ﹤0.01% | 3288 |
|
|
2019
Q2 | $795K | Buy |
48,535
+14,641
| +43% | +$230K | ﹤0.01% | 3923 |
|
|
2019
Q1 | $578K | Sell |
33,894
-239,335
| -88% | -$3.57M | ﹤0.01% | 4026 |
|
|
2018
Q4 | $3.73M | Buy |
273,229
+127,275
| +87% | +$2.37M | 0.01% | 2092 |
|
|
2018
Q3 | $4.18M | Buy |
145,954
+45,432
| +45% | +$1.32M | 0.01% | 2036 |
|
|
2018
Q2 | $2.75M | Buy |
100,522
+61,046
| +155% | +$1.48M | 0.01% | 2409 |
|
|
2018
Q1 | $833K | Sell |
39,476
-9,406
| -19% | -$231K | ﹤0.01% | 3436 |
|
|
2017
Q4 | $939K | Buy |
+48,882
| New | +$1.13M | ﹤0.01% | 3398 |
|
|
2017
Q3 | – | Sell |
-152
| Closed | -$2K | – | 7383 |
|
|
2017
Q2 | $2K | Buy |
152
+81
| +114% | +$1.13K | ﹤0.01% | 7001 |
|
|
2017
Q1 | $1K | Buy |
71
+66
| +1,320% | +$886 | ﹤0.01% | 7091 |
|
|
2016
Q4 | $0 | Sell |
5
-568
| -99% | -$8.53K | ﹤0.01% | 7280 |
|
|
2016
Q3 | $10K | Sell |
573
-130
| -18% | -$2.52K | ﹤0.01% | 6536 |
|
|
2016
Q2 | $15K | Buy |
+703
| New | +$18.7K | ﹤0.01% | 6320 |
|
Other funds holding NTLA
AIM
VPM
VCM
RP
